Colfax Corporation (CFX - Free Report) reported better-than-expected results for the first quarter of 2020, with earnings surpassing estimates by 2.7%. This was the company’s 18th consecutive quarter of impressive results. Also, the quarter’s sales beat the consensus estimate by 3.1%.
The machinery company’s adjusted earnings in the reported quarter were 38 cents per share, surpassing the Zacks Consensus Estimate of 37 cents. Moreover, the bottom line gained 2.7% from the year-ago figure of 37 cents.
In the quarter under review, Colfax’s pro forma revenues were $816.4 million, reflecting a year-over-year decline of 4.3%. The result suffered from a 1.4% decline in the existing businesses (due to the pandemic impact on demand) and a 2.9% impact from forex woes.
However, the company’s revenues surpassed the Zacks Consensus Estimate of $792.2 million.
Further, its sales from continuing operations increased 19.4%, including gains from the DJO Global acquisition.
The company currently reports under two business segments — Fabrication Technology and Medical Technology. The segmental information is briefly discussed below:
Revenues from Fabrication Technology totaled $525.5 million, declining 6.2% year over year. Fall in the existing businesses had an adverse impact of 2.2%, while forex woes negatively influenced by 4%.
Revenues from Medical Technology totaled $290.8 million, reflecting a year-over-year decline of 0.6%. The existing businesses contributed 0.3%, offset by a 0.9% adverse impact of forex woes.
In the quarter under review, Colfax’s cost of sales grew 10.7% year over year to $468.1 million. Selling, general and administrative expenses increased 17.5% year over year to $291.3 million. It represented 35.7% of revenues.
Adjusted earnings before interest, tax and amortization (EBITA) in the quarter under review increased 5.9% year over year to $95.5 million. Also, adjusted EBITA margin decreased 150 bps to 11.7%. Interest expenses in the quarter grew 13.6% year over year to $24.8 million.
Balance Sheet and Cash Flow
Exiting the first quarter, Colfax had cash and cash equivalents of $365.6 million, surging 233.5% from $109.6 million at the end of the last reported quarter. Long-term debt balance increased 10% sequentially to $2,513 million.
Notably, the company repaid borrowings of $364.4 million under its revolving credit facilities and other. Further, it raised $608.7 million in cash through the same means.
In the first quarter, Colfax generated net cash of $56.2 million from operating activities as compared with $72.3 million net cash used in the year-ago quarter. Capital used for purchasing property, plant and equipment was $31.1 million, reflecting a year-over-year rise of 27.7%.
The company noted that necessary actions are being taken to ensure workers’ safety, continue serving customers and maintaining healthy liquidity position. Also, cost-management actions (reduction of more than $100 million targeted in the second quarter) have been considered to mitigate some financial stress caused by the pandemic.
The company expects demand to be lowest in the second quarter, while anticipates improvements thereof. Further, it suspended the previously provided projections for 2020.
Colfax Corporation Price, Consensus and EPS Surprise